World's Best Scientists 2026 revealed!
VIEW LIST
David R. Gandara

D-Index & Metrics

Medicine

D-Index
113
Citations
70197
World Ranking
4839
National Ranking
2622

David R. Gandara publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where David R. Gandara sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 900 publications — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

David R. Gandara D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where David R. Gandara sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 113 D-Index — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

David R. Gandara is affiliated with the University of California, Davis in the United States and has a research focus primarily in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their work spans several subfields, including Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology, and Pathology and Forensic Medicine.

The main topics covered by Gandara's research include Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, Lung Cancer Research Studies, Colorectal Cancer Treatments and Studies, Lung Cancer Diagnosis and Treatment, and Genetic factors in colorectal cancer.

Gandara has contributed to numerous publications, with frequent appearances in key journals such as:

  • Journal of Clinical Oncology
  • Journal of Thoracic Oncology
  • Clinical Lung Cancer
  • Annals of Oncology
  • JCO Precision Oncology

Representative recent papers associated with Gandara's research include:

  • "Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer" (2021), published in Journal of Thoracic Oncology
  • "Efficacy of chemotherapy and atezolizumab in patients with non-small-cell lung cancer receiving antibiotics and proton pump inhibitors: pooled post hoc analyses of the OAK and POPLAR trials" (2020), published in Annals of Oncology
  • "Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non-Small-Cell Lung Cancer" (2023), published in Journal of Clinical Oncology
  • "Phase II Randomized Study of Ramucirumab and Pembrolizumab Versus Standard of Care in Advanced Non-Small-Cell Lung Cancer Previously Treated With Immunotherapy-Lung-MAP S1800A" (2022), published in Journal of Clinical Oncology
  • "Atezolizumab Versus Docetaxel in Pretreated Patients With NSCLC: Final Results From the Randomized Phase 2 POPLAR and Phase 3 OAK Clinical Trials" (2020), published in Journal of Thoracic Oncology

Frequent coauthors collaborating with Gandara include:

  • Karen Kelly
  • Jonathan W. Riess
  • Mary W. Redman
  • Roy S. Herbst
  • Philip C. Mack

Best Publications

  • Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial.

    Achim Rittmeyer;Fabrice Barlesi;Daniel Waterkamp;Keunchil Park

  • Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer

    Giorgio Vittorio Scagliotti;Purvish Parikh;Joachim von Pawel;Bonne Biesma

  • Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer

    Timothy Winton;Robert Livingston;David H Johnson;James Rigas

  • Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy Regimens

    Frank V. Fossella;Russell DeVore;Ronald N. Kerr;Jeffrey Crawford

  • Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial

    Naiyer A. Rizvi;Julien Mazières;David Planchard;Thomas E. Stinchcombe

  • Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Cisplatin in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Southwest Oncology Group Trial

    Karen Kelly;John Crowley;Paul A. Bunn;Cary A. Presant

  • Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial

    Kathy S Albain;R Suzanne Swann;Valerie W Rusch;Andrew T Turrisi

  • Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805.

    Kathy S. Albain;Valerie W. Rusch;John J. Crowley;Thomas W. Rice

  • Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab

    David R. Gandara;Sarah M. Paul;Marcin Kowanetz;Erica Schleifman

  • Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer.

    Reginald V N Lord;Jan Brabender;David R Gandara;Vicente Alberola

  • Increased Epidermal Growth Factor Receptor Gene Copy Number Detected by Fluorescence In Situ Hybridization Associates With Increased Sensitivity to Gefitinib in Patients With Bronchioloalveolar Carcinoma Subtypes: A Southwest Oncology Group Study

    Fred R. Hirsch;Marileila Varella-Garcia;Jason McCoy;Howard West

  • Proposal for classifying the acute emetogenicity of cancer chemotherapy.

    Paul J. Hesketh;Mark G. Kris;Steven M. Grunberg;Thomas Beck

  • Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: A Southwest Oncology Group study

    Antoinette J. Wozniak;John J. Crowley;Stanley P. Balcerzak;Geoffrey R. Weiss

  • Phase III Trial of Maintenance Gefitinib or Placebo After Concurrent Chemoradiotherapy and Docetaxel Consolidation in Inoperable Stage III Non–Small-Cell Lung Cancer: SWOG S0023

    Karen Kelly;Kari Chansky;Laurie E. Gaspar;Kathy S. Albain

  • Phase II Clinical Trial of Bevacizumab and Low-Dose Metronomic Oral Cyclophosphamide in Recurrent Ovarian Cancer: A Trial of the California, Chicago, and Princess Margaret Hospital Phase II Consortia

    Agustin A. Garcia;Hal Hirte;Gini Fleming;Dongyun Yang

  • Customizing cisplatin based on quantitative excision repair cross-complementing 1 mRNA expression: a phase III trial in non-small-cell lung cancer.

    Manuel Cobo;Dolores Isla;Bartomeu Massuti;Ana Montes

  • Prospective Evaluation of Cancer Clinical Trial Accrual Patterns: Identifying Potential Barriers to Enrollment

    Primo N. Lara;Roger Higdon;Nelson Lim;Karen Kwan

  • Phase I Study of Navitoclax (ABT-263), a Novel Bcl-2 Family Inhibitor, in Patients With Small-Cell Lung Cancer and Other Solid Tumors

    Leena Gandhi;D. Ross Camidge;Moacyr Ribeiro De Oliveira;Philip Bonomi

  • Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124

    Primo N. Lara;Ronald Natale;John Crowley;Heinz Josef Lenz

  • Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC

    Christian Rolfo;Philip C. Mack;Giorgio V. Scagliotti;Paul Baas

Frequent Co-Authors

Primo N. Lara
Primo N. Lara University of California, Davis
Roy S. Herbst
Roy S. Herbst Yale University
John Crowley
John Crowley Washington University in St. Louis
James H. Doroshow
James H. Doroshow National Institutes of Health
Suresh S. Ramalingam
Suresh S. Ramalingam Emory University
Heinz-Josef Lenz
Heinz-Josef Lenz University of Southern California
Kathy S. Albain
Kathy S. Albain Loyola University Chicago
Everett E. Vokes
Everett E. Vokes University of Chicago
Vassiliki A. Papadimitrakopoulou
Vassiliki A. Papadimitrakopoulou The University of Texas MD Anderson Cancer Center
Laurel A. Beckett
Laurel A. Beckett University of California, Davis

External Links

Personal website of David R. Gandara

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers in medicine doesn’t always mean heading straight for an MD program. There are a variety of related online degrees and specialized pathways to launch or advance your healthcare career. For those seeking to enter the workforce quickly, fast track medical lpn programs offer a streamlined route to becoming a Licensed Practical Nurse, often with flexible schedule options.

If mental health care interests you, consider the growing demand for psychiatric nurse practitioners. Accredited psych np programs online prepare RNs for advanced roles in mental health, opening doors to both clinical and leadership opportunities.

Not all healthcare careers involve direct patient care. Earning a health care administration online degree enables you to work behind the scenes in management and policy development. For those considering advanced leadership, a cheapest online mha program can provide a cost-effective, flexible pathway to upper-level positions.

Whether you are seeking clinical expertise or administrative leadership, these online programs can help you tailor your medical career to your interests, budget, and timeline.

Best Scientists Citing David R. Gandara

Rafael Rosell

Rafael Rosell

Autonomous University of Barcelona

Publications: 180

Frances A. Shepherd

Frances A. Shepherd

Princess Margaret Cancer Centre

Publications: 171

Benjamin Besse

Benjamin Besse

University of Paris-Saclay

Publications: 140

Mark G. Kris

Mark G. Kris

Memorial Sloan Kettering Cancer Center

Publications: 125

Ming-Sound Tsao

Ming-Sound Tsao

Princess Margaret Cancer Centre

Publications: 120

Giorgio V. Scagliotti

Giorgio V. Scagliotti

University of Turin

Publications: 114

Enriqueta Felip

Enriqueta Felip

Vall d'Hebron Institut de Recerca

Publications: 108

Mark A. Socinski

Mark A. Socinski

University of North Carolina at Chapel Hill

Publications: 106

Silvia Novello

Silvia Novello

University of Turin

Publications: 104

Chandra P. Belani

Chandra P. Belani

Penn State Cancer Institute

Publications: 102

Martin Reck

Martin Reck

LungenClinic Grosshansdorf

Publications: 101

Corey J. Langer

Corey J. Langer

University of Pennsylvania

Publications: 99

Pasi A. Jänne

Pasi A. Jänne

Harvard University

Publications: 99

Yi-Long Wu

Yi-Long Wu

Guangdong Provincial People’s Hospital

Publications: 99

Natasha B. Leighl

Natasha B. Leighl

Princess Margaret Cancer Centre

Publications: 96

Johan Vansteenkiste

Johan Vansteenkiste

KU Leuven

Publications: 94

Trending Scientists

David J. Sellmyer

David J. Sellmyer

University of Nebraska–Lincoln

António M. Cunha

António M. Cunha

University of Minho

Scott Hauck

Scott Hauck

University of Washington

Ali A. Orouji

Ali A. Orouji

Semnan University

Ata Sarajedini

Ata Sarajedini

University of Florida

Katsumi Midorikawa

Katsumi Midorikawa

RIKEN

Peter Schilke

Peter Schilke

University of Cologne

Malcolm R. Sears

Malcolm R. Sears

McMaster University

Nouchine Hadjikhani

Nouchine Hadjikhani

Harvard Medical School

Mohammad Mahmudur Rahman

Mohammad Mahmudur Rahman

University of Newcastle Australia

Mervyn P. Freeman

Mervyn P. Freeman

British Antarctic Survey

Milind Y. Desai

Milind Y. Desai

Cleveland Clinic

Britta Denise Hardesty

Britta Denise Hardesty

CSIRO Ocean and Atmosphere

Lukas Cizek

Lukas Cizek

Sewanee: The University of the South

Chris R. Fuller

Chris R. Fuller

Virginia Tech

Pingsha Dong

Pingsha Dong

University of Michigan–Ann Arbor

Related Medicine Rankings & Guides

2026 Best Online Bachelor’s Degrees in Nutritional Science Programs

2026 Best Online Bachelor’s Degrees in Nutritional Science Programs
2026 Best Online DNP Programs

2026 Best Online DNP Programs
2026 Best PharmD Accelerated Degree Programs

2026 Best PharmD Accelerated Degree Programs
2026 Best Online Nurse Practitioner Degree Programs

2026 Best Online Nurse Practitioner Degree Programs
2026 Best Online Medical & Healthcare Certificate Programs

2026 Best Online Medical & Healthcare Certificate Programs
2026 Best Online MSN in Forensic Nursing Programs

2026 Best Online MSN in Forensic Nursing Programs
2026 Best Online BSN to FNP Programs

2026 Best Online BSN to FNP Programs
2026 Cost of LPN Programs & Schools

2026 Cost of LPN Programs & Schools
2026 Most Affordable Online Accelerated BSN Programs for Non-Nurses

2026 Most Affordable Online Accelerated BSN Programs for Non-Nurses
2026 Best Online Master’s in Clinical Research Programs

2026 Best Online Master’s in Clinical Research Programs
2026 Fastest Online Pharmacy Technician Certificate Programs

2026 Fastest Online Pharmacy Technician Certificate Programs
2026 Easiest Medical Degree Programs

2026 Easiest Medical Degree Programs
2026 Best Online Respiratory Therapy Programs

2026 Best Online Respiratory Therapy Programs
2026 Best Online Nurse Leadership DNP Programs

2026 Best Online Nurse Leadership DNP Programs
2026 Fastest Online Nutrition Degree Programs

2026 Fastest Online Nutrition Degree Programs
2026 Best Shortest Online PMHNP Certificate Programs

2026 Best Shortest Online PMHNP Certificate Programs
2026 Best Nurse Practitioner Programs in Oklahoma – Accredited Schools Online & Campus

2026 Best Nurse Practitioner Programs in Oklahoma – Accredited Schools Online & Campus
2026 Best Online Nursing Degree Programs

2026 Best Online Nursing Degree Programs
2026 Fastest Online Master's Degree in Healthcare Management Programs

2026 Fastest Online Master's Degree in Healthcare Management Programs
2026 Fastest Online MSN in Health/Nursing Informatics Programs

2026 Fastest Online MSN in Health/Nursing Informatics Programs
2026 Most Affordable Online BSN to DNP Degree Programs

2026 Most Affordable Online BSN to DNP Degree Programs

Recently Published Articles

2026 Different Types of Security Management Degrees and Their Salaries

2026 Different Types of Security Management Degrees and Their Salaries
2026 Fastest Online Graduate Certificate Nurse Midwifery Programs

2026 Fastest Online Graduate Certificate Nurse Midwifery Programs
2026 Online Mathematics Bachelor's Degree Programs for Adult Learners Returning to School

2026 Online Mathematics Bachelor's Degree Programs for Adult Learners Returning to School
2026 AI Master's Degrees for HR Professionals

2026 AI Master's Degrees for HR Professionals
2026 How to Become a Radiology Technician in California

2026 How to Become a Radiology Technician in California
2026 Cheapest and Shortest Online Psychology Degree Programs That Pay Well: Cost, Duration, and Salary Outlook

2026 Cheapest and Shortest Online Psychology Degree Programs That Pay Well: Cost, Duration, and Salary Outlook
2026 Best ABSN Programs - Accelerated BSN Programs in Utah: Online & Campus

2026 Best ABSN Programs - Accelerated BSN Programs in Utah: Online & Campus
2026 Best Accelerated Project Management Degree Programs Online

2026 Best Accelerated Project Management Degree Programs Online
2026 What Can You Do with a Kinesiology Master's Degree? Careers, Salaries & Growth

2026 What Can You Do with a Kinesiology Master's Degree? Careers, Salaries & Growth
2026 Online Mechanical Engineering Degree Programs Costs: Tuition & Fees

2026 Online Mechanical Engineering Degree Programs Costs: Tuition & Fees
2026 Top-Rated Online MBA Programs for Career Advancement

2026 Top-Rated Online MBA Programs for Career Advancement
2026 Most Affordable Online Psychiatric Nurse Practitioner Programs

2026 Most Affordable Online Psychiatric Nurse Practitioner Programs
2026 Most Popular Concentrations in Healthcare Management Degrees

2026 Most Popular Concentrations in Healthcare Management Degrees
2026 Child Psychology Degree Master's Programs Accepting Students Now

2026 Child Psychology Degree Master's Programs Accepting Students Now
2026 Credit Requirements for a Mechanical Engineering Degree Explained

2026 Credit Requirements for a Mechanical Engineering Degree Explained
2026 Cheapest Way to Get a Teaching Credential in Los Angeles, CA: Degree Requirements & Certification

2026 Cheapest Way to Get a Teaching Credential in Los Angeles, CA: Degree Requirements & Certification
2026 Can You Get Into a Social Work Program with a Low GPA? Admission Chances & Workarounds

2026 Can You Get Into a Social Work Program with a Low GPA? Admission Chances & Workarounds
2026 Artificial Intelligence Degree Programs That Accept Transfer Credits

2026 Artificial Intelligence Degree Programs That Accept Transfer Credits
2026 Online Entrepreneurship Bachelor's Degree Programs With No Application Fee

2026 Online Entrepreneurship Bachelor's Degree Programs With No Application Fee
2026 How Fast Can I Finish an RN to BSN

2026 How Fast Can I Finish an RN to BSN
2026 Best Online Early Childhood Development Degree Programs

2026 Best Online Early Childhood Development Degree Programs